Inventor
Robert A. Mantei
Inventor
Franklin, WI, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds42%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes20%
Y02ATechnologies for adaptation to climate change5%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
10,035,800Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors20189,321,764'Dihydro-pyrrolopyridinone inhibitors'20169,303,025'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20169,296,741'Bromodomain inhibitors'20169,174,982'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20159,125,913'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,073,855'BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,072,748'BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,051,315'Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition'20159,045,420'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,034,875'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20159,029,404'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20158,586,754'BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20138,580,794'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,563,735'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20138,557,983'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,546,399'Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,536,180'Pyrimidine inhibitors of kinase activity'20138,486,933'Pyrimidine inhibitors of kinase activity'20138,354,422'Pyrimidine inhibitors of kinase activity'20138,067,409'Protein kinase inhibitors'20117,772,231'Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors'20107,491,718'Sulfonamides having antiangiogenic and anticancer activity'20097,323,570'Farnesyltransferase inhibitors'20087,211,595'Farnesyltransferase inhibitors'20077,056,925'Urea kinase inhibitors'20065,268,374'Non-peptide renin inhibitors'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993–2013Patents assigned to ABBOTT LAB (8)· patent assignee history
1993Based in Milwaukee, WI, US· patent location history
2006–2018Based in Franklin, WI, US· patent location history
2011–2015Patents assigned to WANG GARY T (10)· patent assignee history
2011–2015Patents assigned to MANTEI ROBERT A (8)· patent assignee history
2013–2018Patents assigned to ABBVIE INC (19)· patent assignee history
2013Patents assigned to DOHERTY GEORGE A (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBVIE INC | 19 | 2013–2018 |
| WANG GARY T | 10 | 2011–2015 |
| ABBOTT LAB | 8 | 1993–2013 |
| MANTEI ROBERT Aself | 8 | 2011–2015 |
| DOHERTY GEORGE A | 5 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Franklin, WI, US | 26 | 2006–2018 |
| Milwaukee, WI, US | 1 | 1993 |